Last reviewed · How we verify
Tenofovir Alafenamide Film coated Tablet
Tenofovir Alafenamide Film coated Tablet is a Small molecule drug developed by Humanis Saglık Anonim Sirketi. It is currently in Phase 1 development.
At a glance
| Generic name | Tenofovir Alafenamide Film coated Tablet |
|---|---|
| Sponsor | Humanis Saglık Anonim Sirketi |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE: A Multi-Center, Single-Arm, Open-Label, Phase 4 Study Assessing the Safety and Efficacy of B/F/TAF in HIV-Positive Adults Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks (PHASE4)
- UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children (PHASE2)
- Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study (PHASE1)
- Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB) (PHASE2)
- A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection (PHASE2)
- A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (PHASE2)
- An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants (PHASE2)
- Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tenofovir Alafenamide Film coated Tablet CI brief — competitive landscape report
- Tenofovir Alafenamide Film coated Tablet updates RSS · CI watch RSS
- Humanis Saglık Anonim Sirketi portfolio CI
Frequently asked questions about Tenofovir Alafenamide Film coated Tablet
What is Tenofovir Alafenamide Film coated Tablet?
Tenofovir Alafenamide Film coated Tablet is a Small molecule drug developed by Humanis Saglık Anonim Sirketi.
Who makes Tenofovir Alafenamide Film coated Tablet?
Tenofovir Alafenamide Film coated Tablet is developed by Humanis Saglık Anonim Sirketi (see full Humanis Saglık Anonim Sirketi pipeline at /company/humanis-sagl-k-anonim-sirketi).
What development phase is Tenofovir Alafenamide Film coated Tablet in?
Tenofovir Alafenamide Film coated Tablet is in Phase 1.